Bassel Nazha, MD, MPH (@basselnazha) 's Twitter Profile
Bassel Nazha, MD, MPH

@basselnazha

Assistant Professor @EmoryMedicine | Genitourinary Oncologist @WinshipAtEmory | Opinions are my own.

ID: 1554055728

calendar_today28-06-2013 21:35:37

319 Tweet

497 Takipçi

646 Takip Edilen

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Abs#4510 #ASCO24 ASCO Modified FOLFIRINOX for first line Rx of advanced urachal carcinoma. Doses, regimen and results👇Encouraging ORR~61%. Key takeaways 👇 OncoAlert UroToday.com

Abs#4510 #ASCO24 <a href="/ASCO/">ASCO</a> Modified FOLFIRINOX for first line Rx of advanced urachal carcinoma. Doses, regimen and results👇Encouraging ORR~61%. Key takeaways 👇 <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a>
Rana McKay, MD, FASCO (@drranamckay) 's Twitter Profile Photo

Amazing to hear the vision for the NCI for rapid trial activation, rapid accrual, virtual CTO, innovation unit for expediting pragmatic trials, and data integration! ⁦UC San Diego Health Moores Cancer Center⁩ #ASCO24 ⁦Dr. Kimryn Rathmell

Amazing to hear the vision for the NCI for rapid trial activation, rapid accrual, virtual CTO, innovation unit for expediting pragmatic trials, and data integration! ⁦<a href="/UCSDCancer/">UC San Diego Health Moores Cancer Center</a>⁩ #ASCO24 ⁦<a href="/NCIDirector/">Dr. Kimryn Rathmell</a>⁩
Aakash Desai, MD, MPH, FASCO (@adesaimd) 's Twitter Profile Photo

LAURA Ph 3: Osimertinib vs Placebo #ASCO24 ASCO ➡️ mPFS: 39.1 vs 5.6 mo (HR 0.16) ‼️ ➡️ 24-mo PFS: 65% vs 13% 📈 ➡️ 81% received osi at progression 💊, Good! ➡️AE discontinuation**: 13% vs 5% ⚠️ Can't wait for Suresh S. Ramalingam, MD, FASCO's presentation today! 🎤 #ASCO24 OncoAlert Data

LAURA Ph 3: Osimertinib vs Placebo #ASCO24 <a href="/ASCO/">ASCO</a> 

➡️ mPFS: 39.1 vs 5.6 mo (HR 0.16) ‼️
➡️ 24-mo PFS: 65% vs 13% 📈
➡️ 81% received osi at progression 💊, Good! 
➡️AE discontinuation**: 13% vs 5% ⚠️

Can't wait for <a href="/RamalingamMD/">Suresh S. Ramalingam, MD, FASCO</a>'s presentation today! 🎤 #ASCO24 <a href="/OncoAlert/">OncoAlert</a> Data
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

❗️Make sure not to miss this education session and my talk on “Recognizing, Celebrating, and Supporting #IMGs in Oncology” at #ASCO24 ❗️ Today, 10-10:15 AM Room S102 ASCO OncoAlert IMG Oncologists

❗️Make sure not to miss this education session and my talk on “Recognizing, Celebrating, and Supporting #IMGs in Oncology” at #ASCO24 ❗️

Today, 10-10:15 AM
Room S102

<a href="/ASCO/">ASCO</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/IMG_Oncologists/">IMG Oncologists</a>
Jacqueline T. Brown, MD (@jackiebrown_md) 's Twitter Profile Photo

🔥 session w these ⭐️s at #ASCO24 👊personal brand = what people think when they think about YOU (we all have one) 👊social media is one sphere of influence but think of your Venn diagram of spheres 👊self-promotion isn’t a dirty word for women 👊be authentic Winship Cancer Institute of Emory University

Jordan Ciuro, MD (@jordanciuro) 's Twitter Profile Photo

Expanding the application of PSMA therapy #GU25 Exciting new data on the horizon. Trials on trials on trial… and even more to come. Check out mechanisms to optimize PSMA theranostics 🔎Work needed on mechanism/resistance in PSMA neg disease 🔎We need to understanding tumor

Expanding the application of PSMA therapy #GU25 

Exciting new data on the horizon. Trials on trials on trial… and even more to come. Check out mechanisms to optimize PSMA theranostics

🔎Work needed on mechanism/resistance in PSMA neg disease
🔎We need to understanding tumor
Pavlos Msaouel (@pavlosmsaouel) 's Twitter Profile Photo

1/5 People living with sickle-cell disease (SCD) face ↑ cancer risk, including #RenalMedullaryCarcinoma. Our latest Immunity study suggests a culprit is the reshaping CD8⁺ T cell chromatin by SCD 👉authors.elsevier.com/sd/article/S10… #MsaouelLab

1/5 People living with sickle-cell disease (SCD) face ↑ cancer risk, including #RenalMedullaryCarcinoma. Our latest <a href="/ImmunityCP/">Immunity</a> study suggests a culprit is the reshaping CD8⁺ T cell chromatin by SCD 👉authors.elsevier.com/sd/article/S10… #MsaouelLab
Ibrahim Azar, MD (@ibrahimazaronc) 's Twitter Profile Photo

🩺🎓 Training teaches the medicine, but not always the whole picture. 💡If you're starting your first attending job, you may find our article with Ivy Riano, M.D. on aspects of oncology that aren't taught in training helpful. 👉connection.asco.org/do/eight-aspec… #ASCOconnection ASCO